Skip to main content

Advertisement

Log in

New insights into the pathophysiology of pes cavus in Charcot–Marie–Tooth disease type 1A duplication

  • Review
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Forefoot pes cavus is a cardinal sign of Charcot–Marie–Tooth disease (CMT). This review is focused on the pathophysiology of pes cavus in CMT1A duplication, which is the most common subtype of the disease. Assessment of foot deformities in CMT1A, their prevalence and proposed mechanisms, and recent contributions of magnetic resonance imaging studies of lower-leg and foot musculature are revised. Special attention is given to papers on foot deformities at initial stages of the disease. We conclude that pes cavus is an early and age-dependent manifestation of CMT1A duplication. Selective denervation of intrinsic foot musculature, particularly of the lumbricals, and not imbalance of lower-leg muscles, seems to be the initial mechanism causing reduced ankle flexibility and forefoot cavus deformity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Alexander IJ, Johnson KA (1989) Assessment and management of pes cavus in Charcot–Marie–Tooth disease. Clin Orthop Relat Res 246:273–281

    PubMed  Google Scholar 

  2. Amato AA, Reilly MM (2011) The death panel for Charcot–Marie–Tooth panels. Ann Neurol 69:1–4

    Article  PubMed  Google Scholar 

  3. Azmaipairashvili Z, Riddle EC, Scavina M, Kumar SJ (2005) Correction of cavovarus foot deformity in Charcot–Marie–Tooth disease. J Pediatr Orthop 25:360–365

    Article  PubMed  Google Scholar 

  4. Berciano J, Combarros O, Calleja PoloJM, Leno C (1989) The application of nerve conduction and clinical studies to genetic counseling in hereditary motor and sensory neuropathy type I. Muscle Nerve 12:302–306

    Article  PubMed  CAS  Google Scholar 

  5. Berciano J, García A, Calleja J, Combarros O (2000) Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot–Marie–Tooth disease 1A duplication. Neuromuscul Disord 10:419–424

    Article  PubMed  CAS  Google Scholar 

  6. Berciano J, Combarros O (2003) Hereditary neuropathies. Curr Opin Neurol 16:613–622

    Article  PubMed  Google Scholar 

  7. Berciano J, García A, Combarros O (2003) Initial semeiology in children with Charcot–Marie–Tooth disease 1A duplication. Muscle Nerve 27:34–39

    Article  PubMed  Google Scholar 

  8. Berciano J, Gallardo E, García A, Combarros O (2006) Pes cavus pathogenesis in Charcot–Marie–Tooth disease type 1A. Brain 129:e51

    Article  Google Scholar 

  9. Berciano J, Gallardo E, García A, Ramón C, Mateo I, Infante J, Rodríguez-Rodríguez E, Combarros O (2008) CMT1A duplication: refining the minimal adult phenotype. J Peripher Nerv Syst 13:310–312

    Article  PubMed  Google Scholar 

  10. Bienfait HM, Verhamme C, van Schaik IN, Koelman JH, de Visser BW, de Haan RJ, Baas F, van Engelen BG, de Visser M (2006) Comparison of CMT1A and CMT2: similarities and differences. J Neurol 253:1572–1580

    Article  PubMed  Google Scholar 

  11. Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonobe T, Le Forestier N, Agid Y, Brice A, Bouche P (1997) Charcot–Marie–Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120:813–823

    Article  PubMed  Google Scholar 

  12. Bouché P, Gherardi R, Cathala HP, Lhermitte F, Castaigne P (1983) Peroneal muscular atrophy. Part 1. Clinical and electrophysiological study. J Neurol Sci 61:389–399

    Article  PubMed  Google Scholar 

  13. Burns J, Crosbie J (2005) Weight bearing ankle dorsiflexion range of motion in idiopathic pes cavus compared with normal and pes cavus feet. The Foot 15:91–94

    Article  Google Scholar 

  14. Burns J, Ryan MM, Ouvrier RA (2009) Evolution of foot and ankle manifestations in children with CMT1A. Muscle Nerve 39:158–166

    Article  PubMed  Google Scholar 

  15. Chung KW, Suh BC, Shy ME, Cho SY, Yoo JH, Park SW, Moon H, Park KD, Choi KG, Kim S, Kim SB, Shim DS, Kim SM, Sunwoo IN, Choi BO (2008) Different clinical and magnetic resonance imaging features between Charcot–Marie–Tooth disease type 1A and 2A. Neuromuscul Disord 18:610–618

    Article  PubMed  CAS  Google Scholar 

  16. Combarros O, Calleja J, Polo JM, Berciano J (1987) Prevalence of hereditary motor and sensory neuropathy in Cantabria. Acta Neurol Scand 75:9–12

    Article  PubMed  CAS  Google Scholar 

  17. Davies DV, Coupland RE (1974) Gray’s anatomy. Descriptive and applied. Longmans, London, pp 727–736

    Google Scholar 

  18. Dyck PJ, Lambert EH (1968) Lower motor and primary sensory neuron diseases with peroneal muscular atrophy I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 39:1032–1038

    Google Scholar 

  19. Dyck PJ, Chance P, Lebo R, Carney AJ (1993) Hereditary motor and sensory neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy, 3rd edn. WB Saunders Co, Philadelphia, pp 1094–1136

    Google Scholar 

  20. Farber JM, Buckwalter KA (2002) MR imaging in nonneoplastic muscle disorders of the lower extremity. Radiol Clin N Am 40:1013–1031

    Article  PubMed  Google Scholar 

  21. Fleckenstein JL, Watumull D, Conner KE, Ezaki M, Greenlee RG Jr, Bryan WW, Chason DP, Parkey RW, Peshock RM, Purdy PD (1993) Denervated human skeletal muscle: MR imaging evaluation. Radiology 187:213–218

    PubMed  CAS  Google Scholar 

  22. Gabreëls-Festen AA, Joosten EM, Gabreëls FJ, Jennekens FG, Janssen-van Kempen TW (1992) Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I). J Neurol Sci 107:145–154

    Article  PubMed  Google Scholar 

  23. Gallardo E, García A, Combarros O, Berciano J (2006) Charcot–Marie–Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 129:426–437

    Article  PubMed  Google Scholar 

  24. García A, Combarros O, Calleja J, Berciano J (1998) Charcot–Marie–Tooth disease type 1A with 17p duplication in early infancy and childhood A longitudinal clinical and electrophysiological study. Neurology 50:1061–1067

    PubMed  Google Scholar 

  25. Grant IA, Benstead TJ (2005) Differential diagnosis of polyneuropathy. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Elsevier Saunders, Philadelphia, pp 1163–1180

    Google Scholar 

  26. Guyton GP (2006) Current concepts review: orthopaedic aspects of Charcot–Marie–Tooth disease. Foot Ankle Int 27:1003–1010

    PubMed  Google Scholar 

  27. Harding AE (1995) From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins. Brain 118:809–818

    Article  PubMed  Google Scholar 

  28. Harding AE, Thomas PK (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259–280

    Article  PubMed  CAS  Google Scholar 

  29. Holmes JR, Hansen ST Jr (1993) Foot and ankle manifestations of Charcot–Marie–Tooth disease. Foot Ankle 14:476–486

    PubMed  CAS  Google Scholar 

  30. Hoogendijk JE, De Visser M, Bolhuis PA, Hart AA, Ongerboer de Visser BW (1994) Hereditary motor and sensory neuropathy type I: clinical and neurographical features of the 17p duplication subtype. Muscle Nerve 17:85–90

    Article  PubMed  CAS  Google Scholar 

  31. Jahss MH (1983) Evaluation of the cavus foot for orthopedic treatment. Clin Orthop Relat Res 181:52–63

    PubMed  Google Scholar 

  32. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA (1993) Nerve conduction studies in Charcot–Marie–Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology 43:1806–1808

    PubMed  CAS  Google Scholar 

  33. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA. Uniform slowing of conduction velocities in Charcot–Marie–Tooth polyneuropathy type 1. Neurology 43: 2664-2667

  34. Kendall HO, Kendall FP, Wadsworth GE (1974) Músculos: pruebas y funciones. JIMS, Barcelona

    Google Scholar 

  35. Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, Kamholz J, Shy ME (2000) Neurological dysfunction and axonal degeneration in Charcot–Marie–Tooth disease type 1A. Brain 123:1516–1527

    Article  PubMed  Google Scholar 

  36. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI (1991) DNA duplication associated with Charcot–Marie–Tooth disease type 1A. Cell 66:219–232

    Article  PubMed  CAS  Google Scholar 

  37. Mann RA, Missirian J (1988) Pathophysiology of Charcot–Marie–Tooth disease. Clin Orthop Relat Res 234:221–228

    PubMed  Google Scholar 

  38. Marques W Jr, Freitas MR, Nascimento OJ, Oliveira AB, Calia L, Melo A, Lucena R, Rocha V, Barreira AA (2005) 17p duplicated Charcot–Marie–Tooth 1A: characteristics of a new population. J Neurol 252:972–979

    Article  PubMed  CAS  Google Scholar 

  39. May DA, Disler DG, Jones EA, Balkissoon AA, Manaster BJ (2000) Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. RadoGraphics 20:S295–S313

    Google Scholar 

  40. Nagai MK, Chan G, Guille JT, Kumar SJ, Scavina M, Mackenzie WG (2006) Prevalence of Charcot–Marie–Tooth disease in patients who have bilateral cavovarus feet. J Pediatr Orthop 26:438–443

    Article  PubMed  Google Scholar 

  41. Nelis E, Van Broeckhoven C, De Jonghe P, Löfgren A, Vandenberghe A, Latour P, Le Guern E, Brice A, Mostacciuolo ML, Schiavon F, Palau F, Bort S, Upadhyaya M, Rocchi M, Archidiacono N, Mandich P, Bellone E, Silander K, Savontaus ML, Navon R, Goldberg-Stern H, Estivill X, Volpini V, Friedl W, Gal A et al (1996) Estimation of the mutation frequencies in Charcot–Marie–Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet 4:25–33

    PubMed  CAS  Google Scholar 

  42. Nicholson GA (1991) Penetrance of the hereditary motor and sensory neuropathy Ia mutation: assessment by nerve conduction studies. Neurology 41:547–552

    PubMed  CAS  Google Scholar 

  43. Nicholson GA (2006) The dominantly inherited motor and sensory neuropathies: clinical and molecular advances. Muscle Nerve 33:589–597

    Article  PubMed  CAS  Google Scholar 

  44. Pareyson D, Marchesi C (2009) Diagnosis, natural history, and management of Charcot–Marie–Tooth disease. Lancet Neurol 8:654–667

    Article  PubMed  CAS  Google Scholar 

  45. Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, Barker DF, Martin JJ, De Visser M, Bolhuis PA (1991) Duplication in chromosome 17p11.2 in Charcot–Marie–Tooth neuropathy type Ia (CMT Ia). Neuromuscul Disord 1:93–97

    Article  PubMed  CAS  Google Scholar 

  46. Redmond AC, Crosbie J, Ouvrier RA (2006) Development and validation of a novel rating system for scoring standing foot posture: the Foot Posture Index. Clin Biomech (Bristol, Avon) 21:89–98

    Article  Google Scholar 

  47. Redmond AC, Crane YZ, Menz HB (2008) Normative values for the Foot Posture Index. J Foot Ankle Res 1:6

    Article  PubMed  Google Scholar 

  48. Reilly MM (2000) Classification of the hereditary motor and sensory neuropathies. Curr Opin Neurol 13:561–564

    Article  PubMed  CAS  Google Scholar 

  49. Rose KJ, Burns J, North KN (2010) Factors associated with foot and ankle strength in healthy preschool-age children and age-matched cases of Charcot–Marie–Tooth disease type 1A. J Child Neurol 25:463–468

    Article  PubMed  Google Scholar 

  50. Sabir M, Lyttle D (1983) Pathogenesis of pes cavus in Charcot–Marie–Tooth disease. Clin Orthop Relat Res 175:173–178

    PubMed  Google Scholar 

  51. Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME (2011) Charcot–Marie–Tooth disease subtypes and genetic testing strategies. Ann Neurol 69:22–33

    Article  PubMed  Google Scholar 

  52. Shy ME, Garbern JY, Kamholz J (2002) Hereditary motor and sensory neuropathies: a biological perspective. Lancet Neurol 1:110–118

    Article  PubMed  Google Scholar 

  53. Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209–1214

    Article  PubMed  CAS  Google Scholar 

  54. Solari A, Laurà M, Salsano E, Radice D, Pareyson D, CMT-TRIAL Study Group (2008) Reliability of clinical outcome measures in Charcot–Marie–Tooth disease. Neuromuscul Disord 18:19–26

    Article  PubMed  CAS  Google Scholar 

  55. Szigeti K, Lupski JR (2009) Charcot–Marie–Tooth disease. Eur J Hum Genet 17:703–710

    Article  PubMed  CAS  Google Scholar 

  56. Thomas PK, Marques W Jr, Davis MB, Sweeney MG, King RH, Bradley JL, Muddle JR, Tyson J, Malcolm S, Harding AE (1997) The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 120:465–478

    Article  PubMed  Google Scholar 

  57. Tynan MC, Klenerman L, Helliwell TR, Edwards RH, Hayward M (1992) Investigation of muscle imbalance in the leg in symptomatic forefoot pes cavus: a multidisciplinary study. Foot Ankle 13:489–501

    PubMed  CAS  Google Scholar 

  58. Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, Vermeulen M, de Visser M (2004) Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia. J Neurol 251:1491–1497

    Article  PubMed  Google Scholar 

  59. Vinci P, Serrao M, Pierelli F, Sandrini G, Santilli V (2006) Lower limb manual muscle testing in the early stages of Charcot–Marie–Tooth disease type 1A. Funct Neurol 21:159–163

    PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to the patients and family members for their willingness to participate in this study. Patient consent was obtained to publish the figures in this paper. We thank Mr. John Hawins for stylistic revision of the manuscript. This study was supported by CIBERNED and IFIMAV.

Conflicts of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José Berciano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berciano, J., Gallardo, E., García, A. et al. New insights into the pathophysiology of pes cavus in Charcot–Marie–Tooth disease type 1A duplication. J Neurol 258, 1594–1602 (2011). https://doi.org/10.1007/s00415-011-6094-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-011-6094-x

Keywords

Navigation